A Phase I, Open-Label, Dose-Escalation Study to Evaluate

Whitley, Chester B (PI)

Pediatrics - Genetics and Metabolism

Project: Research project

Project Details

Description

A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria

Status	Finished
Effective start/end date	12/18/07 → 12/31/09

Funding

BIOMARIN PHARMACEUTICAL, INC.

View all

View less

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.